These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34345561)

  • 21. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe euglycemic diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor: case report and literature review.
    El Ess MS; ElRishi MA
    Ann Med Surg (Lond); 2023 May; 85(5):2097-2101. PubMed ID: 37228937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
    Chauhan S; Manov A; Dhillon GS; Shah P
    Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage.
    Bińczyk W; Dróżdż O; Siudek B; Głuszczyk AM; Plizga JI; Grajnert FJ
    Eur J Case Rep Intern Med; 2024; 11(6):004567. PubMed ID: 38846667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?
    Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K
    Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Euglycemic diabetic ketoacidosis following traumatic brain injury.
    Jang SW; Lee H
    Am J Emerg Med; 2024 Mar; 77():232.e1-232.e3. PubMed ID: 38216364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Euglycemic diabetic ketoacidosis in a patient with new-onset type 1 diabetes following a ketogenic diet: a potential risk of a dangerous dietary trend.
    Helvaci BC; Erdogan BT; Ozdemir D; Topaloglu O; Cakir B
    Arch Endocrinol Metab; 2024; 68():e230229. PubMed ID: 39420895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath SD; Kumar U; Shrivastava V
    Cureus; 2024 Apr; 16(4):e58341. PubMed ID: 38756291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
    Altowayan WM
    Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet.
    Hayami T; Kato Y; Kamiya H; Kondo M; Naito E; Sugiura Y; Kojima C; Sato S; Yamada Y; Kasagi R; Ando T; Noda S; Nakai H; Takada E; Asano E; Motegi M; Watarai A; Kato K; Nakamura J
    J Diabetes Investig; 2015 Sep; 6(5):587-90. PubMed ID: 26417418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.
    Pfützner A; Klonoff D; Heinemann L; Ejskjaer N; Pickup J
    Endocrine; 2017 Apr; 56(1):212-216. PubMed ID: 28303514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium-glucose cotransporter-2 inhibitors induced euglycemic diabetic ketoacidosis: Two case reports and a review of the literature.
    Bitar ZI; Maadarani OS; Alabdali F; Teama A; Elsawah W; Mohsen MJ; Elzoueiry MM
    Clin Case Rep; 2022 Feb; 10(2):e05440. PubMed ID: 35169474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report.
    Brown F; McColl T
    J Emerg Med; 2018 Jan; 54(1):109-111. PubMed ID: 29157798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights.
    Baek HS; Jeong C; Yang Y; Lee J; Lee J; Lee SH; Cho JH; Sohn TS; Son HS; Yoon KH; Lee EY
    Diabetes Metab J; 2024 Nov; 48(6):1169-1175. PubMed ID: 38853537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative extremity gangrene in a patient with type 2 diabetes taking SGLT2 inhibitors: A case report.
    Wong YC; Liu KL; Lee CL
    Medicine (Baltimore); 2021 Apr; 100(16):e25590. PubMed ID: 33879720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin and glucose infusion could prevent euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter 2 inhibitors.
    Ito T; Sugasawa G; Suzuki F; Sunada M; Iwamuro K; Nakano T; Saito M; Maeba S
    Indian J Thorac Cardiovasc Surg; 2022 Jan; 38(1):87-91. PubMed ID: 34898883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Euglycemic Diabetic Ketoacidosis Due to SGLT2 Inhibitor in a Patient With Gitelman Syndrome: A Therapeutic Dilemma.
    Ahmed T; Karimi H; Hegde V; Lodhi SH
    Cureus; 2021 Oct; 13(10):e19169. PubMed ID: 34873512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
    Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
    Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
    Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL
    AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.